LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

275.03 -2.87

Rezumat

Modificarea prețului

24h

Curent

Minim

263.68

Maxim

283.42

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

41.51

77.256

EPS

1.96

Randament dividend

0.3

Marjă de profit

17.406

Angajați

10,600

EBITDA

17M

215M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+22.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.30%

2.33%

Data viitoare de dividende

19 nov. 2025

Următoarea dată ex-dividende

12 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

361M

20B

Deschiderea anterioară

277.9

Închiderea anterioară

275.03

Sentimentul știrilor

By Acuity

50%

50%

174 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 nov. 2025, 23:38 UTC

Câștiguri

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 nov. 2025, 23:00 UTC

Câștiguri

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 nov. 2025, 22:19 UTC

Câștiguri
Principalele dinamici ale pieței

Block Shares Slide After 3Q Results Miss Estimates

6 nov. 2025, 21:53 UTC

Câștiguri

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 nov. 2025, 23:45 UTC

Câștiguri

Wheaton Precious Metals 3Q Sales $476M >WPM

6 nov. 2025, 23:45 UTC

Câștiguri

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 nov. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 nov. 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

6 nov. 2025, 23:45 UTC

Câștiguri

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 nov. 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 nov. 2025, 23:15 UTC

Câștiguri

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 nov. 2025, 23:14 UTC

Câștiguri

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 nov. 2025, 23:14 UTC

Câștiguri

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 nov. 2025, 23:13 UTC

Câștiguri

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 nov. 2025, 23:08 UTC

Câștiguri

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 nov. 2025, 23:08 UTC

Câștiguri

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 nov. 2025, 23:07 UTC

Câștiguri

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 nov. 2025, 23:07 UTC

Câștiguri

Suzano 3Q Rev BRL12.2B >SUZ

6 nov. 2025, 22:47 UTC

Achiziții, Fuziuni, Preluări

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 nov. 2025, 22:47 UTC

Achiziții, Fuziuni, Preluări

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 nov. 2025, 22:45 UTC

Achiziții, Fuziuni, Preluări

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 nov. 2025, 22:25 UTC

Achiziții, Fuziuni, Preluări

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 nov. 2025, 22:13 UTC

Câștiguri

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 nov. 2025, 22:02 UTC

Câștiguri

Century Aluminum 3Q Sales $632.2M >CENX

6 nov. 2025, 22:02 UTC

Câștiguri

Century Aluminum 3Q Adj EPS 56c >CENX

6 nov. 2025, 21:53 UTC

Câștiguri

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 nov. 2025, 21:52 UTC

Achiziții, Fuziuni, Preluări

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 nov. 2025, 21:51 UTC

Achiziții, Fuziuni, Preluări

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 nov. 2025, 21:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

6 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

22.6% sus

Prognoză pe 12 luni

Medie 347.63 USD  22.6%

Maxim 375 USD

Minim 311 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

174 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat